FERNANDO
URESANDI ROMERO
Ikertzailea 2016-(e)ra arte
María Rosario
Sánchez Martínez
María Rosario Sánchez Martínez-rekin lankidetzan egindako argitalpenak (14)
2022
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
-
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism
Chest, Vol. 161, Núm. 2, pp. 524-534
-
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734
2021
-
Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation
Research and Practice in Thrombosis and Haemostasis, Vol. 5, Núm. 1, pp. 168-178
2020
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry
Thrombosis Update, Vol. 1
2019
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism
Internal and Emergency Medicine
2018
-
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis
Thrombosis Research, Vol. 164, pp. 69-74
-
Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants
Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 4, pp. 684-691
2017
-
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
Research and Practice in Thrombosis and Haemostasis, Vol. 1, Núm. 2, pp. 172-179
-
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation
American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9
-
Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis
Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198
-
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism
American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595